Advertisement
Screener

Verrica Pharmaceuticals Inc. (VRCA) Depreciation

2.8 / 5 stars · 68/120 Roast Me

Verrica Pharmaceuticals Inc. Depreciation

Verrica Pharmaceuticals Inc. (VRCA) reported Depreciation of $32.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:Depreciation · last filed 2026-08-06

  • Verrica Pharmaceuticals Inc. depreciation for the quarter ending 2026-06-30 was $15.00K, a 66.67% decline year-over-year.
  • Verrica Pharmaceuticals Inc. depreciation for the quarter ending 2026-03-31 was $17.00K, a 67.31% decline year-over-year.
  • Verrica Pharmaceuticals Inc. depreciation for the quarter ending 2025-12-31 was $14.00K, a 74.07% decline year-over-year.
  • Verrica Pharmaceuticals Inc. depreciation for the quarter ending 2025-09-30 was $21.81K, a 78.19% decline year-over-year.
  • Verrica Pharmaceuticals Inc. depreciation for fiscal 2025 was $133.00K, a 61.11% decline from fiscal 2024.
  • Verrica Pharmaceuticals Inc. depreciation for fiscal 2024 was $342.00K, a 35.47% decline from fiscal 2023.
  • Verrica Pharmaceuticals Inc. depreciation for fiscal 2023 was $530.00K, a 16.74% increase from fiscal 2022.
  • Verrica Pharmaceuticals Inc. depreciation for fiscal 2022 was $454.00K, a 86.07% increase from fiscal 2021.
Period endDepreciation 3 monthDepreciation 6 monthDepreciation 9 monthDepreciation 12 monthDepreciation 12 month as first filed
2026-06-30$15.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$32.00K
10-Q · filed 2026-08-06
$46.00K
derived: sum of 3 quarters · filed 2026-08-06
$67.81K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$17.00K
10-Q · filed 2026-05-12
$31.00K
derived: sum of 2 quarters · filed 2026-05-12
$52.81K
derived: sum of 3 quarters · filed 2026-05-12
$97.81K
derived: sum of 4 quarters · filed 2026-05-12
2025-12-31$14.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
$35.81K
derived: sum of 2 quarters · filed 2026-03-11
$80.81K
derived: sum of 3 quarters · filed 2026-03-11
$133.00K
10-K · filed 2026-03-11
2025-09-30$21.81K
10-Q · filed 2025-11-14
$66.81K
derived: sum of 2 quarters · filed 2025-11-14
$119.00K
10-Q · filed 2025-11-14
$172.81K
derived: sum of 4 quarters · filed 2026-05-12
2025-06-30$45.00K
10-Q · filed 2025-08-12
$96.00K
10-Q · filed 2026-08-06
$151.00K
derived: sum of 3 quarters · filed 2026-05-12
$251.00K
derived: sum of 4 quarters · filed 2026-05-12
2025-03-31$52.00K
10-Q · filed 2026-05-12
$106.00K
derived: sum of 2 quarters · filed 2026-05-12
$206.00K
derived: sum of 3 quarters · filed 2026-05-12
$306.00K
derived: sum of 4 quarters · filed 2026-05-12
2024-12-31$54.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-11
$154.00K
derived: sum of 2 quarters · filed 2026-03-11
$254.00K
derived: sum of 3 quarters · filed 2026-03-11
$342.00K
10-K · filed 2026-03-11
2024-09-30$100.00K
10-Q · filed 2025-11-14
$200.00K
derived: sum of 2 quarters · filed 2025-11-14
$288.00K
10-Q · filed 2025-11-14
$457.00K
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30$100.00K
10-Q · filed 2025-08-12
$227.00K
10-Q · filed 2025-08-12
$357.00K
derived: sum of 3 quarters · filed 2025-08-12
$457.00K
derived: sum of 4 quarters · filed 2025-08-12
2024-03-31$126.00K
10-Q · filed 2025-05-13
$257.00K
derived: sum of 2 quarters · filed 2025-05-13
$357.00K
derived: sum of 3 quarters · filed 2025-05-13
$457.00K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31$131.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11
$231.00K
derived: sum of 2 quarters · filed 2025-03-11
$331.00K
derived: sum of 3 quarters · filed 2025-03-11
$530.00K
10-K · filed 2025-03-11
2023-09-30$100.00K
10-Q · filed 2024-11-05
$200.00K
derived: sum of 2 quarters · filed 2024-11-05
$399.00K
10-Q · filed 2024-11-05
$462.00K
derived: sum of 4 quarters · filed 2024-11-05
2023-06-30$100.00K
10-Q · filed 2024-08-14
$266.00K
10-Q · filed 2024-08-14
$362.00K
derived: sum of 3 quarters · filed 2024-08-14
$489.00K
derived: sum of 4 quarters · filed 2024-08-14
2023-03-31$131.00K
10-Q · filed 2024-05-13
$262.00K
derived: sum of 2 quarters · filed 2024-05-13
$389.00K
derived: sum of 3 quarters · filed 2024-05-13
$487.00K
derived: sum of 4 quarters · filed 2024-05-13
2022-12-31$131.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29
$258.00K
derived: sum of 2 quarters · filed 2024-02-29
$356.00K
derived: sum of 3 quarters · filed 2024-02-29
$454.00K
10-K · filed 2024-02-29
2022-09-30$127.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$225.00K
derived: sum of 2 quarters · filed 2023-11-09
$323.00K
10-Q · filed 2023-11-09
$465.00K
derived: sum of 4 quarters · filed 2023-11-09
2022-06-30$98.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$196.00K
10-Q · filed 2023-08-08
$338.00K
derived: sum of 3 quarters · filed 2023-08-08
$392.00K
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$98.00K
10-Q · filed 2023-05-09
$240.00K
derived: sum of 2 quarters · filed 2023-05-09
$294.00K
derived: sum of 3 quarters · filed 2023-05-09
$331.00K
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$142.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$196.00K
derived: sum of 2 quarters · filed 2023-03-06
$233.00K
derived: sum of 3 quarters · filed 2023-03-06
$244.00K
10-K · filed 2023-03-06
2021-09-30$54.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
$91.00K
derived: sum of 2 quarters · filed 2022-11-07
$102.00K
10-Q · filed 2022-11-07
$114.00K
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30$37.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$48.00K
10-Q · filed 2022-08-11
$60.00K
derived: sum of 3 quarters · filed 2022-08-11
$65.00K
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$11.00K
10-Q · filed 2022-05-09
$23.00K
derived: sum of 2 quarters · filed 2022-05-09
$28.00K
derived: sum of 3 quarters · filed 2022-05-09
$40.00K
derived: sum of 4 quarters · filed 2022-05-09
2020-12-31$12.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02
$17.00K
derived: sum of 2 quarters · filed 2022-03-02
$29.00K
derived: sum of 3 quarters · filed 2022-03-02
$43.00K
10-K · filed 2022-03-02
2020-09-30$5.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
$17.00K
derived: sum of 2 quarters · filed 2021-11-12
$31.00K
10-Q · filed 2021-11-12
$57.20K
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30$12.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
$26.00K
10-Q · filed 2021-08-10
$52.20K
derived: sum of 3 quarters · filed 2021-08-10
$68.20K
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31$14.00K
10-Q · filed 2021-05-07
$40.20K
derived: sum of 2 quarters · filed 2021-05-07
$56.20K
derived: sum of 3 quarters · filed 2021-05-07
$67.20K
derived: sum of 4 quarters · filed 2021-05-07
2019-12-31$26.20K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17
$42.20K
derived: sum of 2 quarters · filed 2021-03-17
$53.20K
derived: sum of 3 quarters · filed 2021-03-17
$64.20K
10-K · filed 2021-03-17
2019-09-30$16.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
$27.00K
derived: sum of 2 quarters · filed 2020-11-09
$38.00K
10-Q · filed 2020-11-09
$48.30K
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30$11.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05
$22.00K
10-Q · filed 2020-08-05
$32.30K
derived: sum of 3 quarters · filed 2020-08-05
$37.30K
derived: sum of 4 quarters · filed 2020-08-05
2019-03-31$11.00K
10-Q · filed 2020-05-07
$21.30K
derived: sum of 2 quarters · filed 2020-05-07
$26.30K
derived: sum of 3 quarters · filed 2020-05-07
2018-12-31$10.30K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
$15.30K
derived: sum of 2 quarters · filed 2020-03-13
$20.30K
10-K · filed 2020-03-13
$20.29K
10-K · filed 2019-03-07
2018-09-30$5.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
$10.00K
10-Q · filed 2019-11-06
2018-06-30$5.00K
10-Q · filed 2019-08-07

Similar stocks

Stock NameCountryMarket CapPE Ratio
OS Therapies Inc (OSTX)United States$0.076B-2.17
iBio, Inc. (IBIO)United States$0.077B-2.94
MAIA Biotechnology, Inc. (MAIA)United States$0.077B-2.30
Valion Bio, Inc. (VBIO)United States$0.077B
Adicet Bio, Inc. (ACET)United States$0.078B-0.81
Lifevantage Corp (LFVN)United States$0.078B15.40
Aldeyra Therapeutics, Inc. (ALDX)United States$0.074B-5.57
Cingulate Inc. (CING)United States$0.073B-2.64
Spero Therapeutics, Inc. (SPRO)United States$0.073B17.41
Gain Therapeutics, Inc. (GANX)United States$0.080B-4.40